We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For the first time, 2- to 5-year-old patients with a certain type of cystic fibrosis could access cystic fibrosis drugs Kaftrio and Kalydeco.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
How we engage and involve patients and the public in our regulatory decision-making.
General information for medical professionals about the assessing fitness to drive guide.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to confirm a measles diagnosis, manage cases and contacts, control infection, and vaccinate young or partially-covered patients.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Statistics on children and young people’s experiences of admitted NHS hospital care in England in November 2020, December 2020 and January 2021.
This report (HPA-CRCE-028) examines the lifetime risk of radiation-induced cancer to the patient and the risk of harmful heritable effects in their children.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Information about the risks of taking valproate medicines during pregnancy.
Guidance on managing and using bed rails safely.
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
Advice and guidance for healthcare practitioners on the health needs of migrant patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.